Financials
- Fiscal year
- 2024
- Total assets
- €594,034
- Loss
- -€4,758
- Solvency
- 31.7%
Total assets▲ 29.3%
Net result
20182024
Apotheek Ravestijn
ActiveSummary
Apotheek Ravestijn has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €188,072 and a net result of -€4,758. Equity is growing by ~27.9% per year across the filed fiscal years. Its solvency ranks better than 42% of 9630 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (low).
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
How big
€594,034total assets 2024
- Staff
- 1.8 FTE
- Equity
- €188,072
- Loss
- -€4,758
Turnover not published (abridged schema)
Who decides
- Parent
- SCHIPPERS - RAVESTIJN · 100%
Accounts 63 d overdue0 of 6 deeds read
Why 60- Higher-failure-rate sector- Annual accounts: weaker financial profile+ Long track record+ Lower-risk legal formFiled after the deadlineShow the evidence
Checked score
Score 2024
Axes · tick = 2023
Profitability68▼-12
Solvency57▼-10
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11,000 at 30 days acceptable
Liquidity short (current ratio 0.82 against 1.7 in 2023; short-term debt: 62.5% and cash: 4.3% of total assets), and 68.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
31.7%
Return on assets
-0.8%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
19 d late
2022
20 d early
2021
31 d early
2020
5 d early
2019
8 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 3 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · abbreviated…
- Weakest financial yearnet -€4,758
- Annual accounts filedfiscal year 2023 · abbreviated…
Key points
By topic
Board & ownership
- Parent
- SCHIPPERS - RAVESTIJN · 100%
Timeline
- Events
- 14
- Since
- 2016
- 29-08-2025Annual accounts filed
- 31-12-2024Weakest financial year
- 19-08-2024Annual accounts filed
Support & recognitions
- Funding sources
- 1
- Recognitions
- 1 register
- Flemish government
- €2,000awarded · 2022
- FASFC
- 1authorised site
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 07-12-1988
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.